Works matching IS 24734039 AND DT 2024 AND VI 8 AND IP 1


Results: 6
    1
    2
    3
    4
    5
    6

    Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.

    Published in:
    JBMR Plus, 2024, v. 8, n. 1, p. 1, doi. 10.1093/jbmrpl/ziad001
    By:
    • Ward, Leanne M;
    • Högler, Wolfgang;
    • Glorieux, Francis H;
    • Portale, Anthony A;
    • Whyte, Michael P;
    • Munns, Craig F;
    • Nilsson, Ola;
    • Simmons, Jill H;
    • Padidela, Raja;
    • Namba, Noriyuki;
    • Cheong, Hae Il;
    • Sochett, Etienne;
    • Muroya, Koji;
    • Tanaka, Hiroyuki;
    • Pitukcheewanont, Pisit;
    • Gottesman, Gary S;
    • Biggin, Andrew;
    • Perwad, Farzana;
    • Chen, Angel;
    • II, John Lawrence Merritt
    Publication type:
    Article